FDA Safety Communication: FDA Provides Interim Results of Duodenoscope Reprocessing Studies Conducted in Real-World Settings

Stephen B. Hanauer, MD, FACG Chair, ACG FDA Related Matters Committee On December 10, the U.S. Food & Drug Administration (FDA) released interim results from post-market surveillance studies on contamination rates with duodenoscopes after ...

Tri-Society Alert: GI Codes to Be Revalued after CMS Sides with Anthem; E/M Payment Changes Delayed

Late Thursday, November 1st, the Centers for Medicare & Medicaid Services (CMS) released the calendar year (CY) 2019 Medicare Physician Fee Schedule (PFS) final rule, which includes several significant policy and payment changes that are ...

Tri-Society Alert: GI Societies Applaud Long-Overdue Changes to ASC Annual Updates

On November 2, the Centers for Medicare and Medicaid Services (CMS) released the calendar year (CY) 2019 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. The administration ...

Trump Administration Seeking to Lower Costs for Medicare Part B Drugs

On Thursday, CMS announced a pre-regulation (“Advance Notice of Proposed Rulemaking”) seeking input on a new “International Pricing Index” (IPI) payment model related to the costs of drugs administered in physician practices and hospitals.  ...

New CMS Rule: Drug Advertisements Must Include List Prices

On Monday, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule requiring drug manufacturers to list a product’s monthly wholesale price, or the cost for a typical course of treatment, if it is greater than $35 ...

APMs and Value-Based Care in Spotlight.  ACG is here to help!

On Thursday, September 13th, the House Energy & Commerce Subcommittee on Health held a hearing entitled, “Examining Barriers to Expanding Innovative Value-Based Care in Medicare.”  This hearing focused on the efforts to transition the ...